Subclinical Entheseal Involvement in Patients with Psoriasis: An Ultrasound Study

Subclinical enthesopathy in patients with psoriasis and its association with other disease parameters: a power Doppler ultrasonographic study

“…This was contrary to that reported by Naredo et al (19) and Gutierrez et al (21). We found a statistically significant correlation between the PASI score and entheseal US findings; the same was reported by Sakkas et al (24) in patients with psoriatic arthritis and Husic et al (25) in their study using US for diagnosis and follow-up of psoriatic arthritis.…”

“…While Eder et al (20) and Gisondi et al (22) reported a significant correlation of US enthesitis and BMI, which is the same as our study result, Gutierrez et al (21) did not find this correlation depending on the mean GUESS score.…”

“…We found a significant correlation between the patient's age and US enthesitis, as previously reported (19,21,22). Conversely, we found no significant difference between the sex distri- Table 2.…”

Concepts in monitoring enthesitis in patients with spondylarthritis- the role of musculoskeletal ultrasound

“…Comparing with clinical evaluation, US is more sensitive and specific in detecting solitary or multiple elementary inflammatory and structural lesions at the level of the enthesis components and identifies subclinical involvement [3,4,[27][28][29][30][31][32][33]. Indeed, the method has a higher reproducibility in comparison to clinical evaluation [3,4,25,34].…”

The early spondyloarthritis (ESPA): Concept, role of new imaging techniques, therapeutic opportunities and research agenda

“…The most relevant findings revealed by US were thickness and PDUS signal of entheses, probably due to the oedema, increase of vessels and cell infiltration, respectively, described by Mc Gonagle in initial phase of SpA 20 , even if until now a direct comparison between US and histological data was never performed in humans. Interestingly, other recent studies showed the presence of "occult" entheseal abnormalities in psoriasis 21,22,23 and in inflammatory bowel disease (IBD) 24 , without signs and symptoms of SpA and without correlation with the activity indices of disease neither of psoriasis neither of bowel.…”